Market Tracker

06/28 5:16pm ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1134
Delayed Data
As of 3:59pm ET
 -0.0019 / -1.65%
Today’s Change
0.06
Today|||52-Week Range
0.22
+40.87%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.11 - 0.12
Volume641,551
Average volume (3 months)679,265
Market cap$28.6M
Dividend yield--
Data as of 3:59pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.05+4.95%
CBLICleveland Biolabs In...+0.51+19.39%
PTXPernix Therapeutics ...+0.01+1.53%
ITUSITUS Corp-0.16-5.05%
Data as of 3:59pm ET, 06/28/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
General Counsel
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts